NTNU intranasal naloxone trial (NINA-1) study protocol for a double-blind, double-dummy, non-inferiority randomised controlled trial comparing intranasal 1.4 mg to intramuscular 0.8 mg naloxone for prehospital use.
Arnre Kristian SkulbergIda TylleskärAnne-Cathrine BraarudJostein DaleFridtjof HeyerdahlSindre MellesmoMorten ValbergOla DalePublished in: BMJ open (2020)
EudraCT Registry (2016-004072-22) and Clinicaltrials.gov Registry (NCT03518021).